AcuamarkDx

Developer of a cancer screening blood technology designed to detect cancer markers at early stages. The company's technology integrates a suite of novel, multiplexed assays that test for several levels of molecular change through frequent, recurrent, sequential monitoring and screening, enabling doctors to get a scalable, and economical blood-based screening result for early detection of cancer, heart disease, thyroid function and diabetes.